Acupuncture versus topiramate in chronic migraine prophylaxis: A randomized clinical trial

Cephalalgia

Volumn 31, Issue 15, 2011, Pages 1510-1521

  Yang, C P ^a,b   Chang, M H ^c   Liu, P E ^d   Li, T C ^d,e   Hsieh, C L ^e   Hwang, K L ^f   Chang, H H ^b,g  

^a KUANG TIEN GENERAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d Huangkuang University   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^g CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Acupuncture; chronic migraine; prophylaxis; topiramate

Indexed keywords

ANTIMIGRAINE AGENT; TOPIRAMATE;

ACUPUNCTURE ANALGESIA; ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BEDTIME DOSAGE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; DISTRESS SYNDROME; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; ECCHYMOSIS; FATIGUE; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MIGRAINE DISABILITY ASSESSMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NAUSEA; PAIN; PARESTHESIA; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SHORT FORM 36; SOMNOLENCE; TRANSFORMED MIGRAINE; TREATMENT DURATION; TREATMENT RESPONSE;

ACUPUNCTURE; ADULT; AGED; CHRONIC DISEASE; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NEUROPROTECTIVE AGENTS; PAIN; PAIN MEASUREMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 81855187144     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102411420585     Document Type: Article

References (49)

1. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004 ; 24 (Suppl 1). 9-160
2. Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 ; 26: 742-746
3. Olesen J, Tfelt-Hansen P, Ramadan N, Goadsby PJ, Welch KMA The headaches. Philadelphia: Lippincott Williams & Wilkins ; 2005 :
4. Lu SR, Fuh JL, Chen WT, Juang KD, Wang SJ. Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia. 2001 ; 21: 980-986
5. Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: Burden, diagnosis, and satisfaction with treatment. Neurology. 2008 ; 71: 559-566
6. Natoli J, Manack A, Dean B, Butler Q, Turkel CC, Stovner L, et al. Global prevalence of chronic migraine: A systematic review. Cephalalgia. 2010 ; 30: 599-609
7. Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol. 2004 ; 3: 475-483 (Pubitemid 38903098)
8. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007 ; 68: 343-349 (Pubitemid 46184209)
9. Juang KD, Wang SJ, Fuh JL, Lu SR, Su TP. Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache. 2000 ; 40: 818-823
10. Dodick DW. Clinical practice. Chronic daily headache. N Engl J Med. 2006 ; 354: 158-165 (Pubitemid 43076713)
11. Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MF, Tierce J, et al. Economic burden of transformed migraine: Results from the American Migraine Prevalence and Prevention (AMPP) study. Headache. 2009 ; 49: 498-508
12. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia. 2007 ; 27: 814-823 (Pubitemid 46961730)
13. Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache. 2007 ; 47: 170-180
14. Silvestrini M, Bartolini M, Coccia M, Baruffaldi R, Taffi R, Provinciali L. Topiramate in the treatment of chronic migraine. Cephalalgia. 2003 ; 23: 820-824 (Pubitemid 37255424)
15. Bartolini M, Silvestrini M, Taffi R, Lanciotti C, Luconi R, Capecci M, et al. Efficacy of topiramate and valproate in chronic migraine. Clin Neuropharmacol. 2005 ; 28: 277-279 (Pubitemid 44378618)
16. Diener HC, Dodick DW, Goadsby PJ, Bigal ME, Bussone G, Silberstein SD, et al. Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia. 2009 ; 29: 1021-1027
17. Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia. 2010 ; 30: 793-803
18. Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010 ; 30: 804-814
19. Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010 ; 50: 921-936
20. Linde K, Streng A, Jurgens S, Hoppe A, Brinkhaus B, Witt C, et al. Acupuncture for patients with migraine, a randomized controlled trial. JAMA. 2005 ; 293: 2118-2125 (Pubitemid 40617064)
21. Diener HC, Kronfeld K, Boewing G, Lungenhausen M, Maier C, Molsberger A, et al. Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomized controlled clinical trial. Lancet Neurol. 2006 ; 5: 310-316
22. Endres HG, Diener HC, Molsberger A. Role of acupuncture in the treatment of migraine. Expert Rev Neurother. 2007 ; 7: 1121-1134 (Pubitemid 47451019)
23. Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev. 2009 ; 21: CD001218 - CD001218
24. Silberstein S, Tfelt-Hansen P, Dodick DW, Limmroth V, Lipton RB, Pascual J, et al. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia. 2008 ; 28: 484-495 (Pubitemid 351502554)
25. Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M, et al. International Headache Society. The International Classification of Headache Disorders, 2nd edition. (ICHD-II)- revision of criteria for 8.2 medication overuse headache. Cephalalgia. 2005 ; 25: 460-465 (Pubitemid 40769867)
26. MacPherson H, White A, Cummings M, Jobst KA, Rose K, Niemtzow RC. Standards for reporting interventions in controlled trials of acupuncture: The STRICTA recommendations. J Altern Complement Med. 2002 ; 8: 85-89 (Pubitemid 34174391)
27. Griggs C, Jensen J. Effectiveness of acupuncture for migraine: critical literature review. J Adv Nurs. 2006 ; 54: 491-501 (Pubitemid 43709386)
28. White A, Hayhoe S, Hart A, Ernst E. Survey of adverse events following acupuncture (SAFA): a prospective study of 32,000 consultations. Acupunct Med. 2001 ; 19: 84-92 (Pubitemid 34094388)
29. Melchart D, Weidenhammer W, Streng A, Reitmayr S, Hoppe A, Ernst E, et al. prospective investigation of adverse effects of acupuncture in 97733 patients. Arch Inter Med. 2004 ; 164: 104-105 (Pubitemid 38067398)
30. Yamashita H, Tsukayama H, Hori N, Kimura T, Tanno Y. Incidence of adverse reactions associated with acupuncture. J Altern Complement Med. 2000 ; 6: 345-350 (Pubitemid 30655988)
31. Tsukayama H, Yamashita H, Kimura T, Otsuki K. Factors that influence the applicability of sham needle in acupuncture trials: two randomized, single-blind, crossover trials with acupuncture-experienced subjects. Clin J Pain. 2006 ; 22: 346-349 (Pubitemid 44357032)
32. Sun Y, Gan TJ. Acupuncture for the management of chronic headache: a systematic review. Anesth Analg. 2008 ; 107: 2038-2047
33. Manias P, Tagaris G, Karageorgiou K. Acupuncture in headache: a critical review. Clin J Pain. 2000 ; 16: 334-339 (Pubitemid 32046989)
34. Dincer F, Linde K. Sham interventions in randomized clinical trials of acupuncture-a review. Complement Ther Med. 2003 ; 11: 235-242 (Pubitemid 38292335)
35. Lund I, Näslund J, Lundeberg T. Minimal acupuncture is not a valid placebo control in randomised controlled trials of acupuncture: a physiologist's perspective. Chin Med. 2009 ; 4: 1-9
36. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, et al. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force. Eur J Neurol. 2009 ; 16: 968-981
37. Tfelt-Hansen P. A review of evidence-based medicine and meta-analytic reviews in migraine. Cephalalgia. 2006 ; 26: 1265-1274 (Pubitemid 44625677)
38. Silberstein SD, Goadsby PJ. Migraine: preventive treatment. Cephalalgia. 2002 ; 22: 491-512 (Pubitemid 36609343)
39. Allais G, De Lorenzo C, Quirico PE, et al. Acupuncture in the prophylactic treatment of migraine without aura: a comparison with flunarizine. Headache. 2002 ; 42: 855-861 (Pubitemid 35285374)
40. Streng A, Linde K, Hoppe A, et al. Effectiveness and tolerability of acupuncture compared with metoprolol in migraine prophylaxis. Headache. 2006 ; 46: 1492-1502 (Pubitemid 44722187)
41. Cabyoglu MT, Ergene N, Tan U. The mechanism of acupuncture and clinical applications. Int J Neurosci. 2006 ; 116: 115-125 (Pubitemid 43067727)
42. Silberstein SD. Migraine pathophysiology and its clinical implications. Cephalalgia. 2004 ; 24 (Suppl 2). 2-7 (Pubitemid 39626211)
43. Fanciullacci M, De Cesaris F. Preventing chronicity of migraine. J Headache Pain. 2005 ; 6: 331-333 (Pubitemid 41349342)
44. Zijlstra FJ, van den Berg-de Lange I, Huygen FJ, et al. Anti-inflammatory actions of acupuncture. Mediators Inflamm. 2003 ; 12: 59-69 (Pubitemid 36783244)
45. Macedo A, Baños JE, Farré M. Placebo response in the prophylaxis of migraine: A meta-analysis. Eur J Pain. 2008 ; 12: 68-75 (Pubitemid 350046365)
46. Zhang W, Robertson J, Jones AC, Dieppe PA, Doherty M. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum. 2008 ; 67: 1716-1723
47. Oken BS. Placebo effects: clinical aspects and neurobiology. Brain. 2008 ; 131: 2812-2823
48. Park J, white A, Stevinson C, Ernst E, James M. Validating a new non-penetrating sham acupuncture device: two randomized controlled trials. Acupunct Med. 2002 ; 20: 168-174 (Pubitemid 36043132)
49. Schiapparelli P, Allais G, Castagnoli Gabellari I, Rolando S, Terzi MG, et al. Non-pharmacological approach to migraine prophylaxis: part II. Neurol Sci. 2010 ; 31 (Suppl 1). 137-139